Clinical Trials Logo

Depression clinical trials

View clinical trials related to Depression.

Filter by:

NCT ID: NCT06387108 Recruiting - Depression Clinical Trials

Evaluation of a Training Course for Educational Professionals

Start date: April 2024
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the efficacy of a two-hour online training course on depression and mental health in childhood and adolescence in educational professionals to improve depression and mental health literacy. It will further be investigated whether the course leads to changes in attitudes towards the illness (reduction of stigma) and to an increased behavioural confidence and behavioral change in dealing with pupils with symptoms and illnesses.

NCT ID: NCT06385405 Not yet recruiting - Clinical trials for Major Depressive Disorder (MDD)

Electroencephalography-based Precise Repetitive Transcranial Magnetic Stimulation Treatment

Start date: May 2024
Phase: N/A
Study type: Interventional

This study will focus on the hypothesis that repetitive transcranial magnetic stimulation (TMS) based on EEG personalized modulation may be more effective in promoting symptomatic relief of major depressive disorder (MDD), and will rely on the platform of neuroimaging and function brain imaging of Shanghai Mental Health Center (SMHC), an authoritative institution in the field of mental health. We will eventually facilitate optimization of physical therapy for major depressive disorder (MDD).

NCT ID: NCT06385223 Not yet recruiting - Depression Clinical Trials

A Novel Individualized Connectome-guided Approach for Precision Intermittent Theta Burst Stimulation for Depression

Start date: June 1, 2024
Phase: N/A
Study type: Interventional

The Investigators propose to carry out a randomized, double-blind trial to compare the clinical efficacy of an individualized connectome-guided accelerated iTBS vs an anatomically-guided (Beam F3) accelerated iTBS. The study team will recruit both inpatients and outpatients who had been referred for TMS for the treatment of depression.

NCT ID: NCT06384209 Not yet recruiting - Clinical trials for Major Depressive Disorder

The Friendship Bench Plus Trial

FB+
Start date: July 1, 2024
Phase: N/A
Study type: Interventional

The goal of this randomised controlled trial is to enhance the Friendship Bench intervention with antidepressants in adults with moderate to severe depression. The main questions it aims to answer are: 1. Is the combination of the Friendship Bench with nurse-led antidepressants prescribing superior to the Friendship Bench alone? 2. What are the barriers and enablers for the prescription of antidepressants by non-specialists in primary care? Type of study: Randomized controlled superiority trial Participants will be randomly selected and allocated into the control arm or intervention arm. Participants in the control arm will receive six sessions of the Friendship Bench Problem Solving Therapy while those in the intervention arm will receive the Friendship Bench intervention plus Fluoxetine (Sertraline for breastfeeding women).

NCT ID: NCT06384196 Not yet recruiting - Depression Clinical Trials

Identity-Based Transdiagnostic Therapy for Young People With Anxiety and Depression

IBTTYOUNG
Start date: July 2, 2024
Phase: N/A
Study type: Interventional

Depression and anxiety are the most prevalent mental disorders among both the general population and young adults, and transdiagnostic treatments for these patients are mostly based on cognitive-behavioral therapy (CBT). Based on common (transdiagnostic) principles of treatment (e.g., emotional exposure), these approaches have proliferated and demonstrated their efficacy in comparison to disorder-specific treatments. Although there are a few transdiagnostic approaches for children and adolescents, we could not find anyone targeting young people. For this reason, we propose the Identity-Based Transdiagnostic Therapy (IBTT) as a new treatment modality ideally created to address the challenge of improving the outcomes of psychotherapy for young adults with anxiety and/or depression. The IBTT is a psychological treatment for emotional disorders specifically designed for the youths in terms of their attitudes to treatment (attractiveness, engagement), and highly personalized to their construal of self and others. This project will allow testing the hypothesis that a novel brief psychotherapeutic intervention, IBTT, will be more efficacious in the treatment of the anxiety and/or depression of young adults than the well-established CBT-based Unified Protocol.

NCT ID: NCT06383286 Completed - Paralympic Athletes Clinical Trials

The Relationship Between Physical Activity Levels and Anxiety, Depression, Stress of Disabled Athletes

Start date: December 1, 2020
Phase:
Study type: Observational [Patient Registry]

It is aimed to investigate the relationship between anxiety, depression, stress and physical activities of disabled athletes prepared for the paralympic games to be held in Tokyo in 2021, 3 times in total at 2-3 months intervals, and to determine the change over time

NCT ID: NCT06383221 Not yet recruiting - Clinical trials for Perinatal Depression

Study of the Intervention Effect of Stepped-care Models on Depression Symptoms During Pregnancy.

Start date: May 20, 2024
Phase: N/A
Study type: Interventional

In this study, pregnant women were screened and managed for depression in three time windows: early pregnancy, mid-pregnancy, and late pregnancy. Pregnant women who screened positive for depression during pregnancy were dynamically enrolled in the study and stratified into randomized groups based on gestation period (early/mid/late) and randomly assigned to the intervention and control groups on a 1:1 basis. Pregnant women in the intervention group attended a three-week "mental fitness boot camp" and were assessed at 3 weeks, and if they still screened positive for depression, they were offered 4 times one-on-one counseling sessions by the obstetrician. The control group received routine care.

NCT ID: NCT06382532 Not yet recruiting - Depressive Disorder Clinical Trials

Diagnosis of Depressive Disorder Malinger Using the Niacin Skin Response Test (NSRT)

Start date: May 1, 2024
Phase:
Study type: Observational [Patient Registry]

This study will explore the specific response characteristics of the niacin skin response test in the population with depressive disorder malinger. The investigators expect that depressive disorder malinger can be discriminated by the niacin skin reaction test.

NCT ID: NCT06382389 Not yet recruiting - Depression Clinical Trials

Efficacy of EMONO as an add-on Therapy to Conventional Antidepressants for the Treatment of Depressive Symptoms in Nursing-home Residents With Neurocognitive Disorders: a Randomized Controlled Trial-

PROTO-EHPAD
Start date: June 2024
Phase: Phase 2
Study type: Interventional

Depression in neurocognitive disorders (Alzheimers' disease and related disoders) is a highly prevalent condition, especially in nursing homes. While it is associated with significant distress, the current conventional antidepressants have shown only modest efficacy and exposed to potentially severe side effects. Recent evidence suggests that nitrous oxide (N2O) in its most commonly used packaging of EMONO (Equimolar Mixture of Oxygen and Nitrous Oxide) has rapid antidepressant properties and a good safety profile. However, no study has investigating the antidepressant effect of EMONO in a population of depressed older adults with moderate to severe neurocognitive disorders in nursing homes. The principal goal of the PROTO-EHPAD study is to compare the changes in depressive symptoms in such individuals in a randomized controlled trial with a follow up period of 8 weeks, with a dosage escalation procedure.

NCT ID: NCT06382194 Recruiting - Depression Clinical Trials

Decision Making Tool for Firearm Storage

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

This is a one-arm pilot study testing the feasibility and acceptability of a decision aid about safe firearm storage.